ATE136466T1 - Polyhämoglobin durch purinderivate und glutathion stabilisiert - Google Patents

Polyhämoglobin durch purinderivate und glutathion stabilisiert

Info

Publication number
ATE136466T1
ATE136466T1 AT91902885T AT91902885T ATE136466T1 AT E136466 T1 ATE136466 T1 AT E136466T1 AT 91902885 T AT91902885 T AT 91902885T AT 91902885 T AT91902885 T AT 91902885T AT E136466 T1 ATE136466 T1 AT E136466T1
Authority
AT
Austria
Prior art keywords
glutathione
polyhemoglobin
stabilized
periodate
adenosine
Prior art date
Application number
AT91902885T
Other languages
English (en)
Inventor
Mario Feola
Jan S Simoni
Peter C Canizaro
Original Assignee
Univ Texas Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas Tech filed Critical Univ Texas Tech
Application granted granted Critical
Publication of ATE136466T1 publication Critical patent/ATE136466T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
AT91902885T 1989-12-29 1990-12-12 Polyhämoglobin durch purinderivate und glutathion stabilisiert ATE136466T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45907189A 1989-12-29 1989-12-29

Publications (1)

Publication Number Publication Date
ATE136466T1 true ATE136466T1 (de) 1996-04-15

Family

ID=23823294

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91902885T ATE136466T1 (de) 1989-12-29 1990-12-12 Polyhämoglobin durch purinderivate und glutathion stabilisiert

Country Status (15)

Country Link
EP (1) EP0507870B1 (de)
JP (1) JP2954347B2 (de)
KR (1) KR0168866B1 (de)
AT (1) ATE136466T1 (de)
AU (1) AU650439B2 (de)
CA (1) CA2072081C (de)
DE (1) DE69026513T2 (de)
DK (1) DK0507870T3 (de)
ES (1) ES2086532T3 (de)
FI (1) FI105256B (de)
GR (1) GR3019775T3 (de)
IE (1) IE73248B1 (de)
NO (1) NO309799B1 (de)
PT (1) PT96398B (de)
WO (1) WO1991009615A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650388A (en) * 1989-11-22 1997-07-22 Enzon, Inc. Fractionated polyalkylene oxide-conjugated hemoglobin solutions
CA2103680C (en) * 1991-02-12 1999-11-23 Mario Feola Improved blood substitute
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
US5900477A (en) * 1992-01-30 1999-05-04 Baxter International, Inc. Use of hemoglobin in the treatment of hemorrhagic shock
US5264555A (en) * 1992-07-14 1993-11-23 Enzon, Inc. Process for hemoglobin extraction and purification
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
EP0767675A4 (de) * 1995-04-10 1998-08-05 Baxter Int Verwendung von vernetztem hämoglobin zur behandlung von subarachnoidalblutungen
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
JP5410647B2 (ja) * 1999-07-01 2014-02-05 シスメックス株式会社 グリコヘモグロビン分析装置用の標準物質及びコントロール物質
CN116941603A (zh) * 2023-07-21 2023-10-27 浙江康嘉基因技术有限公司 一种新型醛化鸡红细胞的制备方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4401652A (en) * 1980-12-31 1983-08-30 Allied Corporation Process for the preparation of stroma-free hemoglobin solutions
US4473496A (en) * 1981-09-14 1984-09-25 The United States Of America As Represented By The Secretary Of The Army Intramolecularly crosslinked hemoglobin
US4831012A (en) * 1984-03-23 1989-05-16 Baxter International Inc. Purified hemoglobin solutions and method for making same
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants

Also Published As

Publication number Publication date
WO1991009615A1 (en) 1991-07-11
CA2072081C (en) 2002-07-30
JPH05504766A (ja) 1993-07-22
EP0507870A1 (de) 1992-10-14
JP2954347B2 (ja) 1999-09-27
EP0507870A4 (en) 1993-08-11
KR0168866B1 (ko) 1999-01-15
GR3019775T3 (en) 1996-07-31
NO922551L (no) 1992-08-28
DE69026513D1 (de) 1996-05-15
DE69026513T2 (de) 1996-09-12
ES2086532T3 (es) 1996-07-01
DK0507870T3 (da) 1996-06-10
FI105256B (fi) 2000-07-14
NO922551D0 (no) 1992-06-26
EP0507870B1 (de) 1996-04-10
AU7142591A (en) 1991-07-24
FI922937A0 (fi) 1992-06-24
IE73248B1 (en) 1997-05-21
AU650439B2 (en) 1994-06-23
PT96398B (pt) 1998-12-31
CA2072081A1 (en) 1991-06-30
KR920703087A (ko) 1992-12-17
FI922937A (fi) 1992-06-24
IE904717A1 (en) 1991-07-17
NO309799B1 (no) 2001-04-02
PT96398A (pt) 1991-10-31

Similar Documents

Publication Publication Date Title
DE69026513D1 (de) Polyhämoglobin durch purinderivate und glutathion stabilisiert
CA2009637A1 (en) Substituted-1,3-oxathiolanes with antiviral properties
DE3853477D1 (de) Makrozyklische verbindungen.
DK25587A (da) Toer, stabiliseret, partikelformig, fritstroemmende tocopherolsammensaetning
ATE121939T1 (de) Ascorbinsäure-tocopheryl-phosphatdiester zur hemmung der maillard-reaktion.
KR930023370A (ko) 단백질 씨(c) 유도체
CA2100269A1 (en) Use of 1, 3-Oxathiolane Nucleoside Analogues in the Treatment of Hepatitis B
MX9203320A (es) Composicion antialergica que contiene compuestos biciclicos switterionicos.
NZ229453A (en) A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GR3006807T3 (de)
AU652988B2 (en) Method for insuring adequate intracellular glutathione in tissue
GR3034946T3 (en) Preparation of factor ix.
NZ235497A (en) Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation
DE69130483D1 (de) Verbesserter blutersatz
AU626070B2 (en) Anticoagulant peptide alcohols
EP0295350A3 (en) Use of n-û2-(diethylamino)ethyl¨-2-methoxy-4-û(1-h 4,5-dihydro-2-imidazolyl)amino¨-5-chlorobenzamide as an anxiolytic and antipsychotic agent
TH14151EX (th) อนุพันธ์ต่าง ๆ ของอิมิดาโซลที่เป็นตัวต่อต้านฤทธิ์แอนจิโอเทนซิน ii, การเตรียมสารเหล่านี้และการใช้สารเหล่านี้บำบัดโรค
TH14318EX (th) นิวคลีโอไซด์ที่ใช้ในการรักษาโรค
TH14318A (th) นิวคลีโอไซด์ที่ใช้ในการรักษาโรค

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time